Scholars@Duke publication: Diatrizoate-containing contrast media inhibit platelet aggregation by disrupting fibrinogen binding

Diatrizoate-containing contrast media inhibit platelet aggregation by disrupting fibrinogen binding

Publication , Journal Article

Sane, DC; Moser, TL; Bashore, TM; Wagner, CL; Greenberg, CS

Published in: Coronary Artery Disease

January 1, 1991

Coronary Artery Disease

0954-6928

January 1, 1991

389 / 396

APA

Chicago

ICMJE

MLA

NLM

Sane, D. C., Moser, T. L., Bashore, T. M., Wagner, C. L., & Greenberg, C. S. (1991). Diatrizoate-containing contrast media inhibit platelet aggregation by disrupting fibrinogen binding. Coronary Artery Disease, 2(3), 389–396. https://doi.org/10.1097/00019501-199105000-00013

Sane, D. C., T. L. Moser, T. M. Bashore, C. L. Wagner, and C. S. Greenberg. “Diatrizoate-containing contrast media inhibit platelet aggregation by disrupting fibrinogen binding.” Coronary Artery Disease 2, no. 3 (January 1, 1991): 389–96. https://doi.org/10.1097/00019501-199105000-00013.

Sane DC, Moser TL, Bashore TM, Wagner CL, Greenberg CS. Diatrizoate-containing contrast media inhibit platelet aggregation by disrupting fibrinogen binding. Coronary Artery Disease. 1991 Jan 1;2(3):389–96.

Sane, D. C., et al. “Diatrizoate-containing contrast media inhibit platelet aggregation by disrupting fibrinogen binding.” Coronary Artery Disease, vol. 2, no. 3, Jan. 1991, pp. 389–96. Scopus, doi:10.1097/00019501-199105000-00013.

Coronary Artery Disease

0954-6928

January 1, 1991

389 / 396